- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Zhujiang Hospital
I alt 101037 resultater
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalUkendtOndartet neoplasma i nasopharynxKina
-
Zhejiang Cancer HospitalUkendtNasopharyngealt karcinomKina
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalUkendtNasopharyngealt karcinomKina
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalUkendtLivmoderhalskræft Stadium IVBKina
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalUkendtNasopharyngealt karcinomKina
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalUkendtIkke-småcellet lungekræft stadie IIIAKina
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalUkendtMetastatisk tyktarmskræftKina
-
Zhejiang Cancer HospitalUkendtSmall Cell Carcinoma of LungKina
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalUkendtIkke-småcellet lungekræftKina
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalIkke rekrutterer endnu
-
Zhejiang Cancer HospitalRekrutteringIkke-resekterbart pancreascarcinomKina
-
Zhejiang Cancer HospitalRekrutteringHER2 genmutation | Galdevejsadenokarcinom Ikke-resekterbartKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuNasopharyngealt karcinom
-
Zhejiang Cancer HospitalRekrutteringMavekræft | Kolorektal cancer | Adenocarcinom i bugspytkirtlen | Galdevejskræft | Gastroøsofageal Junction Adenocarcinom | Leverkræft Stadium IVKina
-
Zhejiang Cancer HospitalRekrutteringKardiotoksicitet induceret af lægemiddelterapi for brystkræftKina
-
Zhejiang Cancer HospitalRekrutteringLeverkræft | CiprofolKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuIkke-småcellet lungekræft stadie III
-
Zhejiang Cancer HospitalIkke rekrutterer endnuAvanceret tyktarmskræftKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuProgressionsfri overlevelse
-
Zhejiang Cancer HospitalRekrutteringStråling | ToripalimabKina
-
Zhejiang Cancer HospitalRekrutteringAvanceret nasopharyngealt karcinomKina
-
Zhejiang Cancer HospitalRekruttering
-
Zhejiang Cancer HospitalRekruttering
-
Zhejiang Cancer HospitalRekrutteringNasopharyngealt karcinomKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuUterine cervikale neoplasmer | Onkolytisk viroterapi | CamrelizumabKina
-
Zhejiang Cancer HospitalRekrutteringKolorektal cancer metastatisk | Mikrosatellit stabil | Mismatch ReparationsdygtigKina
-
Zhejiang Cancer HospitalRekruttering
-
Zhejiang Cancer HospitalRekruttering
-
Zhejiang Cancer HospitalRekrutteringLivmoderhalskræftKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuSmåcellet lungekræft omfattende stadie
-
Zhejiang Cancer HospitalIkke rekrutterer endnuMavekræft, HIPEC, Anti-PD-1 antistof Camrelizumab (SHR-1210), kemoterapi og kirurgiKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuKemoterapi effekt | Gråzone lymfom | Tilbagefald/Gentagelse
-
Zhejiang Cancer HospitalIkke rekrutterer endnu
-
Zhejiang Cancer HospitalIkke rekrutterer endnuLokalt avanceret endetarmskræftKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnu
-
Zhejiang Cancer HospitalIkke rekrutterer endnuIkke-operable trin III NSCLC